AAV Vector Market Size, Share, By Offering (Product Type, Services), Serotype (AV1, AAV2, AAV5, AAV6, and Others), Gene Delivery Method (Ex Vivo, and In Vivo), Target Therapeutic Area (Genetic Disorders, Hematological Disorders, Infectious Disorders, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, and Others), Application Area (Gene Therapy, Cell Therapy, and Vaccines), End-User (Hospitals, Clinics, Research Institutes, Biopharmaceutical Companies, and Others), and Region - Trends, Analysis, and Forecast till 2035

Rising Demand for Gene Therapy is Skyrocketing the Market Expansion

AAV vectors are currently thought to be the most effective platform for delivering genes in gene therapy treatments, so as more gene therapies are created and used, the need for AAV vectors to deliver those genes also grows significantly. This is due to the safety profile, ability to target different tissues, and long-term expression potential of AAV vectors in comparison to other gene delivery systems. As a result, the market for AAV vectors is growing as a direct result of the growing demand for gene therapy.